Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Vita Therapeutics, a US-based startup developing cellular therapy treatments for muscular dystrophy, closed a $32m series A round on Wednesday led by its affiliate, biopharmaceutical company Cambrian Biopharma, and backed by Kiwoom Bio, SCM Life Sciences and Early Light Venture. Its technology is based on research by co-founders Douglas Falk (also its CEO) and Peter Andersen at Kennedy Krieger Institute, and Gabsang Lee and Kathryn Wagner at Johns Hopkins University.
Meetecho, an Italy-based developer of real-time web communication technology spun out of University of Naples, secured an undisclosed amount from cloud communication system provider Nfon yesterday in return for a 24.9% stake. The investment was made through a strategic partnership agreement.
Porotech, a UK-based micro-LED production technology developer spun out of University of Cambridge in January 2020, secured £3m ($4.2m) yesterday from investors including the university’s tech transfer office, Cambridge Enterprise. VC fund Speedinvest led the round, which…
